Clinical Trial

Drug-drug Interaction Study of Rifampin and Anaprazole Sodium

Name: Drug-drug Interaction Study of Rifampin and Anaprazole Sodium — clinical trial record (NCT07330531)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Record status

This record was last updated January 9, 2026 (before its estimated February 5, 2026 completion). Its status may not reflect the trial's current state.

Summary

A drug-drug interaction study designed to evaluate the drug-drug interaction between rifampin capsules and anaprazole sodium enteric-coated tablets in healthy adult subjects

Trial Details

NCT Number	NCT07330531
Lead Sponsor	Xuanzhu Biopharmaceutical Co., Ltd.
Conditions	Drug-drug Interaction Study
Enrollment	24 participants
Start Date	2026-01-04
Primary Completion	2026-02-05 (estimated)
Study Completion	2027-07-21 (estimated)
Updated on ClinicalTrials.gov	2026-01-09